BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34518368)

  • 1. Isoform-Specific Reduction of the Basic Helix-Loop-Helix Transcription Factor TCF4 Levels in Huntington's Disease.
    Nurm K; Sepp M; Castany-Pladevall C; Creus-Muncunill J; Tuvikene J; Sirp A; Vihma H; Blake DJ; Perez-Navarro E; Timmusk T
    eNeuro; 2021; 8(5):. PubMed ID: 34518368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
    J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactions.
    L'Episcopo F; Drouin-Ouellet J; Tirolo C; Pulvirenti A; Giugno R; Testa N; Caniglia S; Serapide MF; Cisbani G; Barker RA; Cicchetti F; Marchetti B
    Cell Death Dis; 2016 Apr; 7(4):e2206. PubMed ID: 27124580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 5' exon usage and splicing.
    Sepp M; Kannike K; Eesmaa A; Urb M; Timmusk T
    PLoS One; 2011; 6(7):e22138. PubMed ID: 21789225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of Kidins220 isoforms in Huntington's disease.
    Sebastián-Serrano Á; Simón-García A; Belmonte-Alfaro A; Pose-Utrilla J; Santos-Galindo M; Del Puerto A; García-Guerra L; Hernández IH; Schiavo G; Campanero MR; Lucas JJ; Iglesias T
    Brain Pathol; 2020 Jan; 30(1):120-136. PubMed ID: 31264746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
    Dufour BD; McBride JL
    Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia susceptibility gene Tcf4 in the brain.
    Brzózka MM; Radyushkin K; Wichert SP; Ehrenreich H; Rossner MJ
    Biol Psychiatry; 2010 Jul; 68(1):33-40. PubMed ID: 20434134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The basic helix-loop-helix transcription factor TCF4 impacts brain architecture as well as neuronal morphology and differentiation.
    Schoof M; Hellwig M; Harrison L; Holdhof D; Lauffer MC; Niesen J; Virdi S; Indenbirken D; Schüller U
    Eur J Neurosci; 2020 Jun; 51(11):2219-2235. PubMed ID: 31919899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Intellectual Disability and Schizophrenia Associated Transcription Factor TCF4 Is Regulated by Neuronal Activity and Protein Kinase A.
    Sepp M; Vihma H; Nurm K; Urb M; Page SC; Roots K; Hark A; Maher BJ; Pruunsild P; Timmusk T
    J Neurosci; 2017 Oct; 37(43):10516-10527. PubMed ID: 28951451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms.
    Hebb AL; Robertson HA; Denovan-Wright EM
    Neuroscience; 2004; 123(4):967-81. PubMed ID: 14751289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M2 Cortex Circuitry and Sensory-Induced Behavioral Alterations in Huntington's Disease: Role of Superior Colliculus.
    Conde-Berriozabal S; García-Gilabert L; García-García E; Sitjà-Roqueta L; López-Gil X; Muñoz-Moreno E; Boutagouga Boudjadja M; Soria G; Rodríguez MJ; Alberch J; Masana M
    J Neurosci; 2023 May; 43(18):3379-3390. PubMed ID: 37001992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
    Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical Network Dynamics Is Altered in Mouse Models of Huntington's Disease.
    Donzis EJ; Estrada-Sánchez AM; Indersmitten T; Oikonomou K; Tran CH; Wang C; Latifi S; Golshani P; Cepeda C; Levine MS
    Cereb Cortex; 2020 Apr; 30(4):2372-2388. PubMed ID: 31761935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
    Spires TL; Grote HE; Garry S; Cordery PM; Van Dellen A; Blakemore C; Hannan AJ
    Eur J Neurosci; 2004 May; 19(10):2799-807. PubMed ID: 15147313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degeneration of ipRGCs in Mouse Models of Huntington's Disease Disrupts Non-Image-Forming Behaviors Before Motor Impairment.
    Lin MS; Liao PY; Chen HM; Chang CP; Chen SK; Chern Y
    J Neurosci; 2019 Feb; 39(8):1505-1524. PubMed ID: 30587542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenesis in the R6/2 mouse model of Huntington's disease is impaired at the level of NeuroD1.
    Fedele V; Roybon L; Nordström U; Li JY; Brundin P
    Neuroscience; 2011 Jan; 173():76-81. PubMed ID: 20807561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Myocyte Enhancer Factor 2 Levels in the Hippocampus of Huntington's Disease Mice Are Related to Cognitive Dysfunction.
    Vidal-Sancho L; Fernández-García S; Solés-Tarrés I; Alberch J; Xifró X
    Mol Neurobiol; 2020 Nov; 57(11):4549-4562. PubMed ID: 32757160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional Assessment of Striatal mRNAs as Valid Biomarkers of Disease Progression in Three Mouse Models of Huntington's Disease.
    Ghavami A; Olsen M; Kwan M; Beltran J; Shea J; Ramboz S; Duan W; Lavery D; Howland D; Park LC
    J Huntingtons Dis; 2020; 9(1):13-31. PubMed ID: 32007959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.